Cellular Peptidases in Immune Functions and Diseases 2

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Langner, Jürgen (Επιμελητής έκδοσης), Ansorge, Siegfried (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Boston, MA : Springer US, 2002.
Σειρά:Advances in Experimental Medicine and Biology, 477
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 06382nam a22005415i 4500
001 978-0-306-46826-1
003 DE-He213
005 20151103131208.0
007 cr nn 008mamaa
008 100301s2002 xxu| s |||| 0|eng d
020 |a 9780306468261  |9 978-0-306-46826-1 
024 7 |a 10.1007/b112039  |2 doi 
040 |d GrThAP 
050 4 |a QR180-189.5 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
082 0 4 |a 616.079  |2 23 
245 1 0 |a Cellular Peptidases in Immune Functions and Diseases 2  |h [electronic resource] /  |c edited by Jürgen Langner, Siegfried Ansorge. 
264 1 |a Boston, MA :  |b Springer US,  |c 2002. 
300 |a XV, 522 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 477 
505 0 |a Membrane Ectopeptidases with Influence on Immune Functions -- Review: The Role of Membrane Peptidase in Immune Functions -- Structure and Function of Aminopeptidase N -- Modulation of WNT-5At Eexpression by Actinonin: Linkage of APN to the WNT-Pathway? -- Enzymatic Activity Is Not A Precondition For The Intracellular Calcium Increase Mediated By mAbs Specific For Aminopeptidase N/CD13 -- Transforming Growth Factor-? Increases the Expression of Aminopeptidase N/CD13 mRNA and Protein in Monocytes and Monocytic Cell Lines -- Cell-Cell Contact Between Lymphocytes and Fibroblast-Like Synovioctyes Induces Lymphocytic Expression of Aminopeptidase n/cd13 and Results in Lymphocytic Activation -- Natural Substrates of Dipeptidyl Peptidase IV -- Relating Structure to Function in the Beta-Propeller Domain of Dipeptidyl Peptidase IV -- Development of a Tertiary-Structure Model of the C-Terminal Domain of DPP IV -- Post Proline Cleaving Peptidases Having DP IV Like Enzyme Activity -- A New Type of Fluorogenic Substrates for Determination of Cellular Dipeptidyl Peptidese IV (DP IV/CD26) Activity -- Potent Inhibitors of Dipeptidyl Peptidase iv and Their Mechanisms of Inhibition -- N-Terminal HIV-1 Tat Nonapeptides as Inhibitors of Dipeptidyl Peptidase IV. Conformational Characterization -- Signal Transduction Events Induced or Affected by Inhibition of the Catalytic Activity of Dipeptidyl Peptidase IV (DP IV, CD26) -- Specific Inhibitors of Dipeptidyl Peptidase IV Suppress mRNA Expression of DP IV/CD26 and Cytokines -- Dipeptidyl Peptidase IV in Inflammatory CNS Disease -- Dipeptidyl Peptidase IV (CD26): Role in T Cell Activation and Autoimmune Disease -- Effects of Nonapeptides Derived From the N-terminal Structure of Human Immunodeficiency Virus-1 (HIV-1) Tat on Suppression of CD26-Dependent T Cell Growth -- DNA Synthesis in Cultured Human Keratinocytes and Hacat Kerationcytes is Reduced by Specific Inhibition of Dipeptidyl Peptidase IV (CD26) Enzymatic Activity -- Attractin: A Cub-Family Protease Involved in T Cell-Monocyte/Macrophage Interactions -- Analogs of Glucose-Dependent Insulinotropic Polypeptide With Increased Dipeptidyl Peptidase IV Resistance -- Dipeptidyl Peptidase IV (DPP IV, CD26) In Patients With Mental Eating Disorders -- The Membrane-Bound Ectopeptidase CPM as a Marker Of Macrophage Maturation in vitro And in vivo -- Matrix Metalloproteinases (MMP-8, -13 and -14) Interact with the Clotting System and Degrade Fibrinogen and Factor XII (Hagemann Factor) -- The Neprilysin Family in Health and Disease -- Cellular Endopeptidases: New Cathepsins; Results from Knock-out-mice; Regulatory Aspects -- Review: Novel Cysteine Proteases of the Papain Family -- Development and Validation of Homology Models of Human Cathepsins K, S, H, and F -- The Function of Propeptide Domains of Cysteine Proteinases -- Human Cathepsins W and F form A New Subgroup of Cathepsins that is Evolutionary Separated from the Cathepsin B- and L-Like Cysteine Proteases -- Cathepsin K Expression in Human Lung -- Expression of Cathepsins B and L in Human Lung Epithelial Cells is Regulated by Cytokines -- Functions of Cathepsin K in Bone Resorption -- Ceramide as an Activator Lipid of Cathepsin D -- Human Cathepsin X -- A Novel Proteolytic Mechanism for Termination of the Ca2+ Signalling Evoked by Proteinase-Activated Receptor-1 (PAR-1) in Rat Astrocytes -- Natural and Synthetic Inhibitors of The Tumor-Associated Serine Protease Urokinase-Type Plasminogen Activator -- Processing of Interleukin-18 by Human Vascular Smooth Muscle Cells -- Peptidases and Peptidase Inhibitors in Pathogensis of Diseases -- Review: Peptidases and Peptidase Inhibitors in the Pathogenesis of Diseases -- The Role of Proteolysis in Alzheimer’s Disease -- Observing Proteases in Living Cells -- The Role of Cysteine Proteases in Intracellular Pancreatic Serine Protease Activation -- Peptidases in the Asthmatic Airways -- Inactivation of Interleukin-6 by Neutrophil Proteases at Sites of Inflammation -- Antisense Inhibition of Cathepsin Bina Human Osteosarcoma Cell Line -- Protease-Protease Inhibitor Balance in the Gastric Mucosa -- The Role of Bacterial and Host Proteinases in Periodontal Disease -- Multifunctional Role of Proteases in Rhumatic Diseases -- Evidence of Proteolytic Activation of Transforming Growth Factor ? in Synovial Fluid -- Matrix Metalloproteinases and Tace Play A Role in The Pathogenesis of Endometriosis -- Influence of Proliferation, Differentiation and Dedifferentiation Factors on the Expression of the Lysosomal Cysteine Proteinase Cathepsin L (CL) in Thyroid Cancer Cell Lines. 
650 0 |a Medicine. 
650 0 |a Immunology. 
650 0 |a Oncology. 
650 0 |a Rheumatology. 
650 0 |a Medical biochemistry. 
650 0 |a Biochemistry. 
650 1 4 |a Biomedicine. 
650 2 4 |a Immunology. 
650 2 4 |a Biochemistry, general. 
650 2 4 |a Rheumatology. 
650 2 4 |a Oncology. 
650 2 4 |a Medical Biochemistry. 
700 1 |a Langner, Jürgen.  |e editor. 
700 1 |a Ansorge, Siegfried.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9780306463839 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 477 
856 4 0 |u http://dx.doi.org/10.1007/b112039  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
912 |a ZDB-2-BAE 
950 |a Biomedical and Life Sciences (Springer-11642)